2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow PATH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India TV P2-VP8, Rotarix - Rotavirus Infection of Children | Phase 3 | Unknown | PATH | 8200 | 2019-10-10 | 2021-04-09 |
| A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E ORV 116E, Placebo - Viral Gastroenteritis Due to Rotavirus | Phase 3 | Unknown | Bharat Biotech International Limited | 6800 | 2011-03-01 | 2012-06-12 |
RIX4414 vaccine (1)
India (1) · Zambia (1)
Ashish Bavdekar, MD,DCH,DNB (1) · Desiree Witte, MD (1) · Dr. Temsunaro R Chandola, MD, MSc (1) · Gagandeep Kang, MDFRCPathPhD (1) · George Armah, PhD (1) · Roma Chilengi, MD (1)